Logo image of ALHEX.PA

HEXAOM (ALHEX.PA) Stock Fundamental Analysis

EPA:ALHEX - Euronext Paris - Matif - FR0004159473 - Common Stock - Currency: EUR

26.4  +0.5 (+1.93%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALHEX. ALHEX was compared to 31 industry peers in the Household Durables industry. While ALHEX seems to be doing ok healthwise, there are quite some concerns on its profitability. ALHEX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALHEX had positive earnings in the past year.
In the past year ALHEX had a positive cash flow from operations.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

With a decent Return On Assets value of 4.64%, ALHEX is doing good in the industry, outperforming 74.19% of the companies in the same industry.
With a decent Return On Equity value of 12.89%, ALHEX is doing good in the industry, outperforming 67.74% of the companies in the same industry.
The Return On Invested Capital of ALHEX (8.71%) is better than 64.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALHEX is significantly below the industry average of 16.96%.
Industry RankSector Rank
ROA 4.64%
ROE 12.89%
ROIC 8.71%
ROA(3y)1.18%
ROA(5y)N/A
ROE(3y)2.49%
ROE(5y)N/A
ROIC(3y)9.7%
ROIC(5y)N/A
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 3.24%, ALHEX is in line with its industry, outperforming 48.39% of the companies in the same industry.
ALHEX's Profit Margin has improved in the last couple of years.
ALHEX has a Operating Margin of 3.23%. This is in the lower half of the industry: ALHEX underperforms 77.42% of its industry peers.
ALHEX's Operating Margin has been stable in the last couple of years.
ALHEX has a worse Gross Margin (18.56%) than 90.32% of its industry peers.
ALHEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.23%
PM (TTM) 3.24%
GM 18.56%
OM growth 3Y0.03%
OM growth 5YN/A
PM growth 3Y12.33%
PM growth 5YN/A
GM growth 3Y-4.12%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 10 15 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALHEX is creating some value.
Compared to 1 year ago, ALHEX has about the same amount of shares outstanding.
ALHEX has a better debt/assets ratio than last year.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.53 indicates that ALHEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALHEX's Altman-Z score of 2.53 is fine compared to the rest of the industry. ALHEX outperforms 67.74% of its industry peers.
The Debt to FCF ratio of ALHEX is 10.10, which is on the high side as it means it would take ALHEX, 10.10 years of fcf income to pay off all of its debts.
ALHEX's Debt to FCF ratio of 10.10 is in line compared to the rest of the industry. ALHEX outperforms 48.39% of its industry peers.
ALHEX has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
ALHEX has a Debt to Equity ratio of 0.27. This is in the better half of the industry: ALHEX outperforms 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 10.1
Altman-Z 2.53
ROIC/WACC1.32
WACC6.58%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.27 indicates that ALHEX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, ALHEX is doing worse than 64.52% of the companies in the same industry.
ALHEX has a Quick Ratio of 1.02. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.02, ALHEX is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.02
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

ALHEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 247.70%, which is quite impressive.
ALHEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.04% yearly.
ALHEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.43%.
The Revenue has been growing slightly by 5.12% on average over the past years.
EPS 1Y (TTM)247.7%
EPS 3Y18.04%
EPS 5YN/A
EPS Q2Q%-27.34%
Revenue 1Y (TTM)-12.43%
Revenue growth 3Y5.12%
Revenue growth 5YN/A
Sales Q2Q%-24.46%

3.2 Future

ALHEX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.94% yearly.
The Revenue is expected to decrease by -2.72% on average over the next years.
EPS Next Y-41.93%
EPS Next 2Y-16.1%
EPS Next 3Y1.94%
EPS Next 5YN/A
Revenue Next Year-26.49%
Revenue Next 2Y-17.17%
Revenue Next 3Y-6.5%
Revenue Next 5Y-2.72%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.27, which indicates a rather cheap valuation of ALHEX.
Compared to the rest of the industry, the Price/Earnings ratio of ALHEX indicates a rather cheap valuation: ALHEX is cheaper than 80.65% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.88, ALHEX is valued rather cheaply.
ALHEX is valuated reasonably with a Price/Forward Earnings ratio of 10.31.
ALHEX's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.20. ALHEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.27
Fwd PE 10.31
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ALHEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALHEX is cheaper than 100.00% of the companies in the same industry.
ALHEX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ALHEX is more expensive than 64.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.54
EV/EBITDA 1.94
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.1%
EPS Next 3Y1.94%

0

5. Dividend

5.1 Amount

ALHEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HEXAOM

EPA:ALHEX (4/30/2025, 7:00:00 PM)

26.4

+0.5 (+1.93%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)05-07 2025-05-07
Inst Owners15.78%
Inst Owner ChangeN/A
Ins Owners2.81%
Ins Owner ChangeN/A
Market Cap183.22M
Analysts84.44
Price Target37.49 (42.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.67%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.82%
EPS NY rev (3m)-18.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-34.64%
Valuation
Industry RankSector Rank
PE 6.27
Fwd PE 10.31
P/S 0.21
P/FCF 20.54
P/OCF 11.33
P/B 0.82
P/tB 1.4
EV/EBITDA 1.94
EPS(TTM)4.21
EY15.95%
EPS(NY)2.56
Fwd EY9.7%
FCF(TTM)1.29
FCFY4.87%
OCF(TTM)2.33
OCFY8.83%
SpS128.14
BVpS32.16
TBVpS18.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.64%
ROE 12.89%
ROCE 10.96%
ROIC 8.71%
ROICexc 19.41%
ROICexgc 68.35%
OM 3.23%
PM (TTM) 3.24%
GM 18.56%
FCFM 1%
ROA(3y)1.18%
ROA(5y)N/A
ROE(3y)2.49%
ROE(5y)N/A
ROIC(3y)9.7%
ROIC(5y)N/A
ROICexc(3y)21.12%
ROICexc(5y)N/A
ROICexgc(3y)82.51%
ROICexgc(5y)N/A
ROCE(3y)12.34%
ROCE(5y)N/A
ROICexcg growth 3Y-24.93%
ROICexcg growth 5YN/A
ROICexc growth 3Y11.72%
ROICexc growth 5YN/A
OM growth 3Y0.03%
OM growth 5YN/A
PM growth 3Y12.33%
PM growth 5YN/A
GM growth 3Y-4.12%
GM growth 5YN/A
F-Score6
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 10.1
Debt/EBITDA 1.27
Cap/Depr 39.18%
Cap/Sales 0.82%
Interest Coverage 250
Cash Conversion 34.22%
Profit Quality 31%
Current Ratio 1.27
Quick Ratio 1.02
Altman-Z 2.53
F-Score6
WACC6.58%
ROIC/WACC1.32
Cap/Depr(3y)30.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)247.7%
EPS 3Y18.04%
EPS 5YN/A
EPS Q2Q%-27.34%
EPS Next Y-41.93%
EPS Next 2Y-16.1%
EPS Next 3Y1.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.43%
Revenue growth 3Y5.12%
Revenue growth 5YN/A
Sales Q2Q%-24.46%
Revenue Next Year-26.49%
Revenue Next 2Y-17.17%
Revenue Next 3Y-6.5%
Revenue Next 5Y-2.72%
EBIT growth 1Y-10.46%
EBIT growth 3Y5.15%
EBIT growth 5YN/A
EBIT Next Year12.43%
EBIT Next 3Y17.41%
EBIT Next 5YN/A
FCF growth 1Y726.58%
FCF growth 3Y37.31%
FCF growth 5YN/A
OCF growth 1Y188.74%
OCF growth 3Y31.78%
OCF growth 5YN/A